Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma-Reference-Cited by-同舟云学术

Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma

Published:2016-11-21 Issue:1 Volume:92 Page:E11-E13
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Yu Hui¹,Sotillo Elena²,Harrington Colleen²³,Wertheim Gerald¹,Paessler Michele¹,Maude Shannon L.⁴⁵,Rheingold Susan R.⁴⁵,Grupp Stephan A.⁴⁵,Thomas-Tikhonenko Andrei¹²³,Pillai Vinodh¹

Affiliation:

1. Department of Pathology and Laboratory Medicine; Children's Hospital of Philadelphia; Pennsylvania

2. Division of Cancer Pathobiology; Children's Hospital of Philadelphia; Pennsylvania

3. Cell & Molecular Biology Graduate Group, Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania

4. Division of Oncology, The Children's Hospital of Philadelphia; Pennsylvania

5. Department of Pediatrics and the Center for Childhood Cancer Research; Children's Hospital of Philadelphia; Pennsylvania

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24594/fullpdf

Reference8 articles.

1. Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression;Jacobsen;Blood,2015

2. Antibody-modified T cells: CARs take the front seat for hematologic malignancies;Maus;Blood,2014

3. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

4. DNA repair genes are selectively mutated in diffuse large B cell lymphomas;Miranda;J Exp Med,2013

5. Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas;Perez-Callejo;Cancer Treat Rev,2015

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New immune cell engagers for cancer immunotherapy;Nature Reviews Immunology;2024-01-25

2. Standardization of flow cytometric detection of antigen expression;Cytometry Part B: Clinical Cytometry;2024-01-12

3. Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies;Blood;2023-11-16

4. Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments;Journal of Translational Medicine;2023-07-07

5. Role of RNA Splicing Mutations in Diffuse Large B Cell Lymphoma;International Journal of General Medicine;2023-06